Testing a multigene model to predict lethal prostate cancer

PW Kantoff , LA Mucci , K Fall , O Andren
Laboratory Investigation 88

2008
Eine häufige Genfusion im Prostatakarzinom

S Perner , M A Rubin , K Mertz , F Schmidt
Deutsche Medizinische Wochenschrift 134 1483 -1486

1
2009
PD-L1-Expression Nicht-Kleinzelliger Lungenkarzinome: Vergleich immunzyto- und -histologischer Ergebnisse thoraxchirurgisch gewonnener Proben

LIS van der Linde , C Kümpers , W Vogel , DF Heigener
60. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V.

2019
Expression of the embryonic stem cell marker SOX2 in breast carcinoma

T Fehm , R Kurth , C Lengerke , PM Bareiss
Geburtshilfe Und Frauenheilkunde 71 ( 08)

2011
Expression des embryonalen Stammzell-Faktors SOX2 in serösen Ovarialkarzinomen

TN Fehm , AD Hartkopf , D Pham , V Scheible
Geburtshilfe Und Frauenheilkunde 71 ( 08)

2011
Ecotropic viral integration site 1, a novel oncogene in prostate cancer.

A Queisser , S Hagedorn , H Wang , T Schaefer
Oncogene 36 ( 11) 1573 -1584

18
2017
Morphological features of TMPRSS2-ERG gene fusion prostate cancer.

J-M Mosquera , S Perner , F Demichelis , R Kim
The Journal of Pathology 212 ( 1) 91 -101

115
2007
TTF1 expression in non-small cell lung carcinoma: association with TTF1 gene amplification and improved survival.

S Perner , PL Wagner , A Soltermann , C LaFargue
The Journal of Pathology 217 ( 1) 65 -72

74
2009
ERG protein expression and genomic rearrangement status in primary and metastatic prostate cancer-a comparative study of two monoclonal antibodies

M Braun , D Goltz , Z Shaikhibrahim , W Vogel
Prostate Cancer and Prostatic Diseases 15 ( 2) 165 -169

65
2012
ERG rearrangement and protein expression in the progression to castration-resistant prostate cancer

J R Gsponer , M Braun , V J Scheble , T Zellweger
Prostate Cancer and Prostatic Diseases 17 ( 2) 126 -131

18
2014
Prognostic significance of YWHAZ expression in localized prostate cancer.

K Rüenauver , R Menon , M A Svensson , J Carlsson
Prostate Cancer and Prostatic Diseases 17 ( 4) 310 -314

27
2014
An oncogenic role for the multiple endocrine neoplasia type 1 gene in prostate cancer

P L Paris , S Sridharan , A B Hittelman , Y Kobayashi
Prostate Cancer and Prostatic Diseases 12 ( 2) 184 -191

24
2009
[Frequent gene fusion in prostate cancer: clinical applications in diagnosis, prognosis and therapy].

F Schmidt , V Scheble , K Mertz , S Perner
Deutsche Medizinische Wochenschrift 134 1483 -1486

1
2009
TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort.

F Demichelis , K Fall , S Perner , O Andrén
Oncogene 26 ( 31) 4596 -4599

594
2007
Is there a role for dose painting within the prostate in the primal therapy of patients with localized prostate cancer using choline PET/CT, dynamic MRI and CAD or choline MRS?

M Schmuecking , S Perner , C Boltze , H Geyer
Rofo-fortschritte Auf Dem Gebiet Der Rontgenstrahlen Und Der Bildgebenden Verfahren 182

2010
Expression of embryonic stem cell factor Sox2 in serous ovarian carcinomas

T Fehm , DL Pham , V Scheible , C Lengerke
Senologie - Zeitschrift für Mammadiagnostik und -therapie 9 ( 02)

2012